Adrenomedullin Infusion Attenuates Myocardial Ischemia/Reperfusion Injury Through the Phosphatidylinositol 3-Kinase/Akt-Dependent Pathway

Circulation

Volumn 109, Issue 2, 2004, Pages 242-248

  Okumura, Hiroyuki ^a   Nagaya, Noritoshi ^a   Itoh, Takefumi ^a   Okano, Ichiro ^a   Hino, Jun ^a   Mori, Kenji ^a   Tsukamoto, Yoshitane ^a   Ishibashi Ueda, Hatsue ^a   Miwa, Senri ^b   Tambara, Keiichi ^b   Toyokuni, Shinya ^b   Yutani, Chikao ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Hemodynamics; Myocardial infarction; Peptides; Reperfusion

Indexed keywords

ADRENOMEDULLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CORONARY ARTERY LIGATION; DRUG INFUSION; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMIC MONITORING; HEMODYNAMICS; HORMONE ACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADRENOMEDULLIN; ANIMALS; APOPTOSIS; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PEPTIDES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 9144253125     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000109214.30211.7C     Document Type: Article

References (25)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994;338:6-10.
3. Sakata J, Shimokubo T, Kitamura K, et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 1994;352:105-108.
4. Miyao Y, Nishikimi T, Goto Y, et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart. 1998;79:39-44.
5. Nagaya N, Nishikimi T, Yoshihara F, et al. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol Regul Integr Comp Physiol. 2000;278:R1019-R1026.
6. Tsuruda T, Johji K, Kitamura K, et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 1998;31:505-510.
7. Tsuruda T, Johji K, Kitamura K, et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res. 1999;43:958-967.
8. Nagaya N, Satoh T, Nishikimi T, et al. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation. 2000;101:498-503.
9. Nishimatsu H, Suzuki E, Nagata D, et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res. 2001;89:63-70.
10. Matsui T, Tao J, del Monte F, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001;104:330-335.
11. Nagaya N, Nishikimi T, Horio T, et al. Cardiovascular and renal effects of adrenomedullin in rats with heart failure. Am J Physiol. 1999;276:R213-R218.
12. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation. 2002;105:1497-1502.
13. Kurrelmeyer KM, Michael LH, Baumgarten G, et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A. 2000;97:5456-5461.
14. Scarabelli TM, Knight RA, Rayment NB, et al. Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based TUNEL technique enhanced with counterstains. J Immunol Methods. 1999;228:23-28.
15. Gottlieb RA, Burleson KO, Kloner RA, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94:1621-1628.
16. Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest. 1997;100:1363-1372.
17. Kato H, Shichiri M, Marumo F, et al. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology. 1997;138:2615-2620.
18. Sata M, Kakoki M, Nagata D, et al. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension. 2000;36:83-88.
19. Colucci WS. Apoptosis in the heart. N Engl J Med. 1996;335:1224-1226.
20. Yamashita K, Kajstura J, Discher DJ, et al. Reperfusion-activated Akt kinase prevent apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res. 2001;88:609-614.
21. Franke TF, Kaplan DR, Cantley LC, et al. PI3K: downstream AKTion blocks apoptosis. Cell. 1997;88:435-437.
22. Miyao Y, Nishikimi T, Goto Y, et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart. 1998;79:39-44.
23. Yaoita H, Ogawa K, Maehara K, et al. Attenuation of ischemia/reperfusion injury in rats by caspase inhibitor. Circulation. 1998;97:276-281.
24. Wang P, Chen H, Qin H, et al. Overexpression of human copper, zinc-superoxide dismutase (SODI) prevents postischemic injury. Proc Natl Acad Sci U S A. 1998;95:4556-4560.
25. Nagaya N, Goto Y, Satoh T, et al. Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol. 2002;39:754-760.